|
BRMS1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.04436467754476E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.81223957851762E-12 |
| Normal-vs-Stage2 |
9.68970000000402E-05 |
| Normal-vs-Stage3 |
7.59829976715309E-10 |
| Normal-vs-Stage4 |
3.85950160719517E-11 |
| Stage1-vs-Stage2 |
1.959400E-01 |
| Stage1-vs-Stage3 |
6.209400E-01 |
| Stage1-vs-Stage4 |
6.496300E-02 |
| Stage2-vs-Stage3 |
1.554040E-01 |
| Stage2-vs-Stage4 |
1.627880E-02 |
| Stage3-vs-Stage4 |
1.970970E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.28785870856518E-13 |
| Normal-vs-AfricanAmerican |
4.042200E-04 |
| Normal-vs-Asian |
2.33279999994895E-06 |
| Caucasian-vs-AfricanAmerican |
2.479800E-01 |
| Caucasian-vs-Asian |
3.271800E-01 |
| AfricanAmerican-vs-Asian |
7.204200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.9773072068574E-13 |
| Normal-vs-Female |
3.79539732975331E-11 |
| Male-vs-Female |
7.723900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.22669693584044E-11 |
| Normal-vs-Age(41-60Yrs) |
4.55759985307225E-10 |
| Normal-vs-Age(61-80Yrs) |
9.5673025057863E-11 |
| Normal-vs-Age(81-100Yrs) |
1.762750E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.773400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.255400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.888200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.263600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.992200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.788400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.591980E-02 |
| Classical-VS-Follicular |
5.540400E-01 |
| Classical-VS-Other |
2.369800E-01 |
| Classical-VS-Normal |
7.92450549624846E-11 |
| Tall-VS-Follicular |
1.249630E-01 |
| Tall-VS-Other |
7.887200E-01 |
| Tall-VS-Normal |
4.71219951947432E-10 |
| Follicular-VS-Other |
4.056400E-01 |
| Follicular-VS-Normal |
1.01439999955488E-07 |
| Other-VS-Normal |
9.364200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.90359958299291E-11 |
| Normal-vs-N1 |
1.3876999549467E-10 |
| N0-vs-N1 |
6.476200E-02 |
|
|
